Network Pharmacology and Molecular Docking Reveal Wenxin Granule’s Anti-Atrial Fibrillation Mechanisms

Authors

    Liangjin Yu, Meng Cai, Weiqin Liu Guizhou university of traditional Chinese Medicine, Guiyang 550005, Guizhou, China Liyang Branch of Jiangsu Provincial Hospital of Traditional Chinese Medicine, Liyang 213399, Jiangsu, China Guizhou university of traditional Chinese Medicine, Guiyang 550005, Guizhou, China

DOI:

https://doi.org/10.18063/apm.v10i2.873

Keywords:

Wenxin granules, Atrial fibrillation, P13K-Akt, Pharmacology, Molecular docking

Abstract

Objective: Wenxin Granules (WXG) is a Chinese medicine preparation made from five traditional Chinese medicines, including Polygonal circumscribe, Synopsis peninsula, Panax nothingness, Succinct, and Chardonnays chines, clinically used for the treatment of atrial fibrillation. The specific components and molecular mechanisms of WXG in treating atrial fibrillation have not been fully clarified. This study will further elucidate the mechanism of action of WXG in treating atrial fibrillation through network pharmacology research and molecular docking techniques. Methods: The components corresponding to the five Chinese herbs were searched in the Herb database and the active components of OB 30%, DL 0.18 were screened according to the TCMSP database, and the relevant targets of the active components were retrieved in Symmap. The above “metacentric particle-active component-target” data were imported into the Cytoscape software to build an intuitive map of the “metacentric particle-active component-target” network. In the GeneCards database, “atrial fibrillation” was used as the keyword to obtain disease-related targets of atrial fibrillation, and the intersection targets of metacellular particles and atrial fibrillation in the Venny 2.1.0 platform. These targets were initially considered to be the targets of metacellular particles in the treatment of atrial fibrillation. The intersection targets were imported into the protein intercorrelation analysis platform, STRING website, to get the PPI to further analyze the relationship between these intersection targets. PPI data were imported into Cytoscape software for more accurate analysis to obtain core targets. The intersection targets were analyzed by the David database and obtained as enrichment analysis for KEGG and GO. Finally, the molecular docking of the core target and the active component was scored with AutoDock series software, and the results were imported into PyMOL display. Conclusion: This study provides a reference for further investigation of the mechanism of antiarrhythmic action, and defines the core targets of the drug phase and selects 191 intersection targets of cardiac particles and atrial fibrillation. The core targets were TP 53, AKT 1, JUN, STAT 3, TNF and IL 6, and the main signaling pathways involved were the PI3K-Akt signaling pathway. KEGG enrichment analysis identified TP 53, AKT 1 and STAT 3 as core targets of metacentric granule (WXG) modulation of atrial fibrillation (AF) through the PI3K-AKT pathway, lipid metabolism and anti-inflammatory signaling pathway. Molecular docking revealed that Acacetin, the major bioactive component of WXG, stabilizes atrial electrophysiology by selectively inhibiting potassium currents, consistent with established antiarrhythmic effects.

References

Shi S, Tag Y, Zhao Q, et al, 2022, Prevalence and Risk of Atrial Fibrillation in China: A National Cross-Sectional Epidemiological Study. Lancet Reg Health West Pac, 23: 100439.

Jin Q, Jiang Y, Fu L, et al, 2020, Wenxin Granule Ameliorates Hypoxia/Reoxygenation-Induced Oxidative Stress in Mitochondria via the PKC-δ/NOX2/ROS Pathway in H9c2 Cells. Oxid Med Cell Longev, 2020: 3245483.

Cai M, Xiang Y, Li Z, et al, 2023, Network Pharmacology and Molecular Docking Predictions of the Active Compounds and Mechanism of Action of Huangkui Capsule for the Treatment of Idiopathic Membranous Nephropathy. Medicine (Baltimore), 102(37): e35214.

Stanzione F, Giangreco I, Cole J, 2021, Use of Molecular Docking Computational Tools in Drug Discovery. Prog Med Chem, 60: 273–343.

Saleh K, Haldar S, 2023, Atrial Fibrillation: A Contemporary Update. Clin Med (Lond), 23(5): 437–441.

Bosch N, Cimini J, Walkey A, 2018, Atrial Fibrillation in the ICU. Chest, 154(6): 1424–1434.

Hendriks J, Gallagher C, Middeldorp M, et al, 2021, Risk Factor Management and Atrial Fibrillation. Europace, 23(23 Suppl 2): ii52–ii60.

O’Keefe E, Sturgess J, O’Keefe J, et al, 2021, Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification. Am J Cardiol, 160: 46–52.

Ding W, Protty M, Davies I, et al, 2022, Relationship Between Lipoproteins, Thrombosis, and Atrial Fibrillation. Cardiovasc Res, 118(3): 716–731.

Wang Y, Chen Q, Huang X, et al, 2023, Acacetin-Loaded Microemulsion for Transdermal Delivery: Preparation, Optimization and Evaluation. Pharm Biol, 61(1): 790–798.

Li G, Wang H, Qin G, et al, 2008, Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs. Circulation, 117(19): 2449–2457.

Liu H, Wang Y, Yang L, et al, 2016, Synthesis of a Highly Water-Soluble Acacetin Prodrug for Treating Experimental Atrial Fibrillation in Beagle Dogs. Sci Rep, 6: 25743.

Wu H, Sun H, Wu W, et al, 2013, Properties and Molecular Determinants of the Natural Flavone Acacetin for Blocking hKv4.3 Channels. PLoS One, 8(3): e57864.

Ren J, Rao B, Ma H, et al, 2012, Effect of Isotexin on Transient Outward Potassium Currents in Rat Ventricular Myocytes. Heart Rhythm, 9(1): 125.

Kuang R, Xu Y, Hong L, et al, 2016, Effect of Acardiac Granules on Early Recurrence After Radiofrequency Ablation in Patients with Atrial Fibrillation. Heart Journal, 2016(5): 546.

Hu H, et al, 2017, Effects of Steady Heart Granules Combined with RAS Inhibitors on Serum IL-6, hs-CRP, MMP-9, NT-proBNP and Left Atrial Remodeling in Patients with Hypertension Complicated with Paroxysmal Atrial Fibrillation. Journal of Modern Integrated Traditional Chinese and Western Medicine, 26(25): 2796–2799.

Da S, 2017, Influence of Inflammation and Atherosclerosis in Atrial Fibrillation. Curr Atheroscler Rep, 19(1): 2.

Wang Y, Chen Q, Huang X, et al, 2023, Acacetin-Loaded Microemulsion for Transdermal Delivery: Preparation, Optimization and Evaluation. Pharm Biol, 61(1): 790–798.

Li G, Wang H, Qin G, et al, 2008, Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs. Circulation, 117(19): 2449–2457.

Liu H, Wang Y, Yang L, et al, 2016, Synthesis of a Highly Water-Soluble Acacetin Prodrug for Treating Experimental Atrial Fibrillation in Beagle Dogs. Sci Rep, 6: 25743.

Wu H, Sun H, Wu W, et al, 2013, Properties and Molecular Determinants of the Natural Flavone Acacetin for Blocking hKv4.3 Channels. PLoS One, 8(3): e57864.

Wu H, Sun H, Wu W, et al, 2022, A Retrospective Observational Study. Front Endocrinol (Lausanne), 13: 1047927.

Yamagishi S, Sotokawauchi A, Matsui T, 2019, Pathological Role of Advanced Glycation End Products (AGEs) and Their Receptor Axis in Atrial Fibrillation. Mini Rev Med Chem, 19(13): 1040–1048.

Liu Y, Bai F, Liu N, et al, 2020, Metformin Improves Lipid Metabolism and Reverses the Warburg Effect in a Canine Model of Chronic Atrial Fibrillation. BMC Cardiovasc Disord, 20(1): 50.

Downloads

Published

2025-06-28